Purification

Purification is one of the most important steps in downstream processing as it separates the product of interest from other contaminants in the fermentation or cell culture broth. There are several unit operations used for purification including centrifugation, flocculation, micro/ultrafiltration, and chromatography.

Centrifugation employs centrifugal force to separate cell debris and insoluble particles from the bulk protein solution. This "clarification" step is usually the first purification step to remove large biomatter before further processing.

In Downstream Processing, Flocculation uses chemicals called flocculants that bind to particulate matter causing it to clump together and precipitate out of solution. The coagulated particles are then removed, often using centrifugation or filtration.

Micro/ultrafiltration utilizes selective membranes to separate molecules based on size. These filtration methods concentrate the product stream while removing cells, cell fragments, and other contaminating biomolecules through a semipermeable membrane.

Chromatography techniques separate biomolecules based on differences in their affinities to bind to solid surfaces like resins or to travel through columns at different rates. Common chromatography methods include affinity, ion-exchange, hydrophobic interaction, and size-exclusion chromatography which can effectively purify the target protein from other similar biomolecules.

Concentration and Diafiltration

After initial purification steps, the product stream still contains buffer salts and other solubilizing components from culture media/lysis buffers that need further removal. Concentration and diafiltration (CF) work to exchange these buffer components for a preferred formulation buffer.

CF uses selective membranes to concentrate the purified protein stream while simultaneously flushing out unwanted contaminants through counter-current flow of formulation buffer. Typical concentration factors range from 10- to 100-fold which significantly reduces volume and exchanges buffer. Tangential flow filtration is a commonly used CF method.

Viral Inactivation/Removal

Viral clearance steps are crucial for downstream processing of biotherapeutics to prevent transmission of adventitious viruses. Common viral reduction approaches include low pH or solvent/detergent treatments, nanofiltration, and use of viral-retentive filters.

Low pH or solvent/detergent treatments disrupt viral envelopes and capsid structures, effectively inactivating viruses. Nanofiltration uses selective membrane pores smaller than virus diameters to physically retain viruses. Viral-retentive filters made of fiber matrices have demonstrated logarithmic reduction in common process viruses. Achieving sufficient viral clearance helps ensure product safety.

Final Filtration and Formulation

The final purified bulk drug substance is normally subjected to terminal sterile filtration prior to filling and finishing. Filters with a nominal pore size of 0.1-0.2 μm reliably retain bacteria and fungi, aseptically clarifying the solution.

Formulation involves adjusting the solution properties like pH, salt concentration, stabilizers, cryoprotectants as needed for optimal drug product stability and delivery. Some biologics are also freeze-dried into cakes or agglomerates to improve long-term storage shelf lives at appropriate temperatures.

Quality Control Testing

At multiple stages, samples are drawn for identity, purity, potency, and safety testing by analytical methods like HPLC, SDS-PAGE, ELISA. Bioburden, endotoxin levels monitor process safety and sterility. Cell banking and characterization ensure consistency. This quality control helps meet regulatory requirements, release final product batches, and improve optimization for consistent commercial manufacturing.

Downstream processing comprises essential unit operations that work together to yield safe, pure, and potent therapeutic biopharmaceuticals from complex fermentation or cell culture harvests. Advances in separation technologies continue enhancing purification efficiencies and capacities to meet growing industry demands. Rigorous quality standards ensure reproducible and reliable manufacturing of biologics for patient use.

 Get More Insights on Downstream Processing

Get this Report in Japanese Language- ダウンストリーム処理

Get this Report in Korean Language-  다운스트림 처리

About Author-

Alice Mutum is a seasoned senior content editor at Coherent Market Insights, leveraging extensive expertise gained from her previous role as a content writer. With seven years in content development, Alice masterfully employs SEO best practices and cutting-edge digital marketing strategies to craft high-ranking, impactful content. As an editor, she meticulously ensures flawless grammar and punctuation, precise data accuracy, and perfect alignment with audience needs in every research report. Alice's dedication to excellence and her strategic approach to content make her an invaluable asset in the world of market insights.

(LinkedIn: www.linkedin.com/in/alice-mutum-3b247b137 )